[HTML][HTML] Effects and clinical implications of sacubitril/valsartan on left ventricular reverse remodeling in patients affected by chronic heart failure: a 24-month follow-up

C Paolini, G Mugnai, C Dalla Valle, A Volpiana… - IJC Heart & …, 2021 - Elsevier
Background Compared to angiotensin inhibition, angiotensin-neprilysin “blockade”
improves mortality and reduces hospitalizations in patients with heart failure (HF) with …

Effects and clinical implications of sacubitril/valsartan on left ventricular reverse remodeling in patients affected by chronic heart failure: A 24-month follow-up

C Paolini, G Mugnai, C Dalla Valle… - … cardiology. Heart & …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Compared to angiotensin inhibition, angiotensin-neprilysin" blockade"
improves mortality and reduces hospitalizations in patients with heart failure (HF) with …

[引用][C] Effects and clinical implications of sacubitril/valsartan on left ventricular reverse remodeling in patients affected by chronic heart failure: A 24-month follow-up

C Paolini, G Mugnai, C Dalla Valle, A Volpiana… - IJC Heart & …, 2021 - cir.nii.ac.jp
Effects and clinical implications of sacubitril/valsartan on left ventricular reverse remodeling in
patients affected by chronic heart failure: A 24-month follow-up | CiNii Research CiNii 国立 …

[HTML][HTML] Effects and clinical implications of sacubitril/valsartan on left ventricular reverse remodeling in patients affected by chronic heart failure: A 24-month follow-up

C Paolini, G Mugnai, C Dalla Valle… - … Journal of Cardiology …, 2021 - ncbi.nlm.nih.gov
abstract Background: Compared to angiotensin inhibition, angiotensin-neprilysin ''blockade”
improves mortality and reduces hospitalizations in patients with heart failure (HF) with …

Effects and clinical implications of sacubitril/valsartan on left ventricular reverse remodeling in patients affected by chronic heart failure: A 24-month follow-up.

C Paolini, G Mugnai, C Dalla Valle… - … Journal of cardiology …, 2021 - europepmc.org
Background Compared to angiotensin inhibition, angiotensin-neprilysin" blockade"
improves mortality and reduces hospitalizations in patients with heart failure (HF) with …

[PDF][PDF] IJC Heart & Vasculature

C Paolinia, G Mugnai, C Dalla Valle, A Volpiana… - 2021 - academia.edu
abstract Background: Compared to angiotensin inhibition, angiotensin-neprilysin ''blockade”
improves mortality and reduces hospitalizations in patients with heart failure (HF) with …

Effects and clinical implications of sacubitril/valsartan on left ventricular reverse remodeling in patients affected by chronic heart failure: A 24-month follow-up.

C Paolini, G Mugnai, C Dalla Valle… - … Journal of cardiology …, 2021 - europepmc.org
Background Compared to angiotensin inhibition, angiotensin-neprilysin" blockade"
improves mortality and reduces hospitalizations in patients with heart failure (HF) with …